{"nctId":"NCT01689779","briefTitle":"High Dose Preoperative Cholecalciferol Supplementation and Perioperative Vitamin D Status","startDateStruct":{"date":"2013-01"},"conditions":["Hypovitaminosis D"],"count":60,"armGroups":[{"label":"Cholecalciferol","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: 100,000 IU cholecalciferol"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]}],"interventions":[{"name":"100,000 IU cholecalciferol","otherNames":["vitamin D3"]},{"name":"Placebo","otherNames":["sugar pill"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Men and women;\n* 18 years or older;\n* Scheduled for elective (non-emergent) colorectal surgery;\n* Cleared for anesthesia; and\n* Expected to stay overnight following surgery\n\nExclusion Criteria:\n\n* Scheduled for a purely laparoscopic procedure;\n* Diagnosis of a terminal illness and/or in hospice care;\n* Inability to sign informed consent;\n* Inability to comply with study protocol;\n* Intending to start vitamin D supplementation within 30 days of surgery;\n* Intending to leave the Boston area during the follow-up period;\n* History of renal stones or hypercalcemia;\n* Medical conditions that can cause hypercalcemia (e.g. metastatic cancer, sarcoidosis, myeloma primary hyperparathyroidism)\n* History of hypercalcemia\n* History of severe anemia (Hematocrit \\<25%)\n* Medications that affect vitamin D metabolism (e.g. anti-epileptics, tuberculosis medication); and\n* Already enrolled or planning to enroll in a research study that would conflict with full participation in the current study or confound the observation or interpretation of the study findings","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Percent (%) Change in 25(OH)D 5 Days Following Supplementation With 100,000 IU Cholecalciferol","description":"3-7 days before surgery, patients will receive 100,000 IU of cholecalciferol (vs. placebo) during their pre-op assessment. They will also have their baseline vitamin D status measured during this initial visit. The main study outcome is to determine if 100,000 IU cholecalciferol can be given preoperatively to safely boost vitamin D status. To assess vitamin D status, we will measure: 1) 25(OH)D and 2) LL37","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"8","spread":"6"},{"groupId":"OG001","value":"-2","spread":"4"}]}]}]},{"type":"SECONDARY","title":"Percent (%) Change in Pre-surgical 25(OH)D Within 24 Hours of Surgery","description":"The goal is to determine whether pre-operative supplementation with 100,000 IU cholecalciferol (vs. placebo) alters the natural course of short-term changes in vitamin D status following surgery. To assess vitamin D status, we will measure: 1) 25(OH)D and 2) LL37.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-5","spread":"6"},{"groupId":"OG001","value":"-4","spread":"4"}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Percent (%) Change in Pre-surgical 25(OH)D 2 Weeks After Surgery","description":"The goal is to determine whether pre-operative supplementation with 100,000 IU cholecalciferol (vs. placebo) alters the natural course of changes in vitamin D status within 10-18 days after surgery. To assess vitamin D status, we will measure: 1) 25(OH)D and 2) LL-37.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3","spread":"7"},{"groupId":"OG001","value":"1","spread":"11"}]}]}]},{"type":"PRIMARY","title":"Percent (%) Change in LL-37 5 Days Following Supplementation With 100,000 IU Cholecalciferol","description":"3-7 days before surgery, patients will receive 100,000 IU of cholecalciferol (vs. placebo) during their pre-op assessment. They will also have their baseline vitamin D status measured during this initial visit. The main study outcome is to determine if 100,000 IU cholecalciferol can be given preoperatively to safely boost vitamin D status. To assess vitamin D status, we will measure: 1) 25(OH)D and 2) LL37","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-10","spread":"17"},{"groupId":"OG001","value":"-5","spread":"12"}]}]}]},{"type":"SECONDARY","title":"Percent (%) Change in Pre-surgical LL-37 Within 24 Hours of Surgery","description":"The goal is to determine whether pre-operative supplementation with 100,000 IU cholecalciferol (vs. placebo) alters the natural course of short-term changes in vitamin D status following surgery. To assess vitamin D status, we will measure: 1) 25(OH)D and 2) LL37.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-3","spread":"24"},{"groupId":"OG001","value":"-5","spread":"31"}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Percent (%) Change in Pre-surgical LL-37 2 Weeks After Surgery","description":"The goal is to determine whether pre-operative supplementation with 100,000 IU cholecalciferol (vs. placebo) alters the natural course of changes in vitamin D status within 10-18 days after surgery. To assess vitamin D status, we will measure: 1) 25(OH)D and 2) LL-37.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"16","spread":"27"},{"groupId":"OG001","value":"2","spread":"37"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":28},"commonTop":[]}}}